Skip to main content
SpringerLink
Log in

Humoral Responses in Type 1 Diabetes Mellitus

  • Published:
Reviews in Endocrine and Metabolic Disorders Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gepts W. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965;14:619.

    Google Scholar 

  2. Sanjeevi CB, Falorni A, Kockum I, Hagopian W, Lernmark Å. HLA and glutamic acid decarboxylase in human insulin-dependent diabetes mellitus. Diabetic Medicine 1996;13:209.

    Google Scholar 

  3. Gambelunghe G, Ghaderi M, Cosentino A, Falorni A, Brunetti P, Falorni A, Sanjeevi CB. Association of MHC Class I chain-related A (MIC-A) gene polymorphism with type I diabetes. Diabetologia 2000;43:507.

    Google Scholar 

  4. Gambelunghe G, Ghaderi M, Tortoioli C, Falorni A, Santeusanio F, Brunetti P, Sanjeevi CB. Two distinct MICA gene markers discriminate major autoimmune diabetes types. J Clin Endocrinol Metab 2001;86:3754.

    Google Scholar 

  5. Sanjeevi CB, Lybrand TP, DeWeese C, Landin-Olsson M, Kockum I, Dahlquist G, Sundkvist G, Stenger D, Lernmark Å. Polymorphic amino acid variations in HLA-DQ are associated with systematic physical property changes and occurrence of insulin-dependent diabetes mellitus. Diabetes 1995;44:125.

    Google Scholar 

  6. Lampeter EF, Homberg M, Quabeck K, Schaefer UW, Wernet P, Bertrams J, Grosse-Wilde H, Gries FA, Kolb H. Transfer of insulindependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993;341:1243.

    Google Scholar 

  7. Vialettes B, Maranichi D. Transfer of insulin-dependent diabetes between HLA-identical siblings by bone marrow transplantation. Lancet 1993;342:174.

    Google Scholar 

  8. Bottazzo GF, Florin-Christensen A, Doniach D. Islet cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974;2:1279.

    Google Scholar 

  9. MacCuish AC, Barnes EW, Irvine WJ, Duncan LJP. Antibodies to pancreatic islet-cells in insulin-dependent diabetics with coexistent autoimmune disease. Lancet 1974;2:1529.

    Google Scholar 

  10. Lernmark Å, Freedman ZR, Hofmann C, et al. Islet-cell-surface antibodies in juvenile diabetes mellitus. N Eng l J Med 1978;299:375.

    Google Scholar 

  11. Huen AH-J, Haneda M, Freedman Z, Lernmark Å, Rubenstein AH, Steiner DF, Jackson RL, Winter RJ, Traisman HS. Quantitative determination of islet cell surface antibodies using 125I-protein A. Diabetes 1983;32:460.

    Google Scholar 

  12. Kanatsuna T, Baekkeskov S, Lernmark, Ludvigsson J. Immunoglobulin from insulin-dependent diabetic children inhibits glucose-induced insulin release. Diabetes 1983;32:520.

    Google Scholar 

  13. Johnson JH, Crider BP, McCorkle K, Alford M, Unger RH. Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus. N Engl J Med 1990;322:653.

    Google Scholar 

  14. Inman LR, MacAllister CT, Chen L, Hughes S, Newgard CB, Kettman JR, Unger RH, Johnson JH. Autoantibodies to the GLUT-2 glucose transporter of beta cells in insulin-dependent diabetes mellitus of recent onset. Proc Natl Acad Sci USA 1993;90:1281–1284.

    Google Scholar 

  15. Juntti-Berggren L, Larsson O, Rorsman P, Ammala C, Bokvist K, Wahlander K, Nicotera P, Dypbukt J, Orrenius S, Hallberg A, Berggren PO. Increased activity of L-type Ca2+ channels exposed to serum from patients with type 1 diabetes. Science 1993;261:86.

    Google Scholar 

  16. Pupilli C, Giannini S, Marchetti P, Lupi R, Antonelli A, Malavasi F, Takasawa S, Okamoto H, Ferrannini E. Autoantibodies to CD38 (ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase) in Caucasian patients with diabetes: Effects on insulin release from human islets. Diabetes 1999;48:2309.

    Google Scholar 

  17. Antonelli A, Tuomi T, Nannipieri M, Fallahi P, Nesti C, Okamoto H, Groop L, Ferrannini E. Autoimmunity to CD38 and GAD in type I and type II diabetes: CD38 and HLA genotypes and clinical phenotypes. Diabetologia 2002;45:1298.

    Google Scholar 

  18. Vandewalle CL, Falorni A, Svanholm S, Lernmark Å, Pipeleers DG, Gorus FK. High diagnostic sensitivity of glutamate decarboxylase autoantibodies in T1DM with clinical onset between age 20 and 40 years. J Clin Endocrinol Metab 1995;80:846.

    Google Scholar 

  19. Idahl LA, Sehlin J, taljiedal IB, Thornell LE. Cytotoxic activation of complement by mouse pancreatic islet cells. Diabetes 1980;29:636.

    Google Scholar 

  20. Crisà L, Mordes JP, Rossini AA. Autoimmune diabetes mellitus in the BB rat. Diabetes Metab Rev 1992;8:9.

    Google Scholar 

  21. Svenningsen A, Dyrberg T, Gerling I, Lernmark Å, Mackay P, Rabinovitch A. Inhibition of insulin release after passive transfer of immunoglobulin from insulin-dependent diabetic children to mice. J Clin Endocrinol Metab 1983;57:1301.

    Google Scholar 

  22. Dobersen MJ, Scharff JE, Ginsberg-Fellner F, Notkins AL. Cytotoxic antibodies to cloned rat islet cells in serum of patients with insulin-dependent diabetes mellitus. N Engl J Med1980;303: 1493.

    Google Scholar 

  23. Rabinovitch A, MacKay P, Ludvigsson J, Lernmark Å. A prospective analysis of islet cell cytotoxic antibodies in insulin-dependent diabetic children: Transient effects of plasmapheresis. Diabetes 1984;33:244.

    Google Scholar 

  24. Schroder D, Kohnert KD, Hehmke B, Besch W, Schmidt S. Modulation of the effect of humoral-mediated cytotoxicity on isolated rat pancreatic islets by glucose. APMIS 1993;101:387.

    Google Scholar 

  25. Dyrberg T, Poussier P, Nakhooda F, Marliss EB, Lernmark Å. Islet cell surface and lymphocyte antibodies often precede the spontaneous diabetes in the BB rat. Diabetologia 1984;26:159.

    Google Scholar 

  26. Charles MA, Suzuki M, Waldeck N. Immune islet killing mechanisms associated with insulin-dependent diabetes: In vitro expression of cellular and antibody-mediated islet cell cytotoxicity in humans. J Immunol 1983;130:1189.

    Google Scholar 

  27. Koevary SB. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated. Diabetes Res 1990;13:133.

    Google Scholar 

  28. Bendelac A, Boitard C, Bedossa P, Bazin H, Bach JF, Carnaud C. Adoptive T-cell transfer of autoimmune non obese diabetic mouse diabetes does not require recruitment of host B lymphocytes. J Immunol 1988;141:2625.

    Google Scholar 

  29. Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, Roep BO. Development of type 1 diabetes despite severe hereditary B-cell deficiency. N Engl J Med 2001;345:1036.

    Google Scholar 

  30. Bottazzo GF, Gleichmann H. Workshop report: Immunology an diabetes workshops: Report of the first international workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 1986;29:125.

    Google Scholar 

  31. Landin-Olsson M. Precision of the islet cell antibody assay depends on the pancreas. J Clin Lab Anal 1990;4:289.

    Google Scholar 

  32. Landin-Olsson M, Palmer JP, Lernmark Å, Blom L, Sundkvist G, Nystrom L, Dahlquist G. Predictive value of islet cell and insulin autoantibodies for type 1 (insulin-dependent) diabetes mellitus in a population-based study of newly diagnosed diabetic and matched control children. Diabetologia 1992;35:1068.

    Google Scholar 

  33. Schiffrin A, Ciampi A, Hendricks L, Rozen R, Weitzer G. Evidence for different clinical subtypes of type 1 diabetes mellitus:Aprospective study. Diabetes Res Clin Pract 1994;23:95.

    Google Scholar 

  34. Riley WJ, Maclaren NK, Krischer J, Spillar RP, Silverstein JH, Schatz DA, Schwartz S, Malone J, Shah S, Vadheim C, Rotter JL. A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 1990;323:1167.

    Google Scholar 

  35. Ziegler AG, Ziegler R, Vardi P, Jackson RA, Soeldner JS, Eisenbarth GS. Life-table analysis of progression to diabetes of anti-insulin autoantibody positive relatives of individuals with type I diabetes. Diabetes 1989;38:1320.

    Google Scholar 

  36. Wagner R, Genovese S, Bosi E, Becker F, Bingley PJ, Bonifacio E, Miles KA, Christie MR, Bottazzo GF, Gale EA. Slow metabolic deterioration towards diabetes in islet cell antibody positive patients with autoimmune polyendocrine disease. Diabetologia 1994;37:365.

    Google Scholar 

  37. Gianani R, Pugliese A, Bonner-Weir S, Shiffrin AJ, Soeldner JS, Erlich H, Awdeh Z, Alper CA, Jackson RA, Eisenbarth GS. Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 1992;41: 347.

    Google Scholar 

  38. Genovese S, Bonifacio E, McNally JM, Dean BM, Wagner R, Bosi E, Gale EA, Bottazzo GF. Distinct cytoplasmic islet cell antibodies with different risks for type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1992;35:385.

    Google Scholar 

  39. Spinas GA, Snorgaard O, Hartling SG, Oberholzer M, Berger W. Elevated proinsulin levels related to islet cell antibodies in firstdegree relatives of IDDM patients. Diabetes Care 1992;15:632.

    Google Scholar 

  40. Baekkeskov S, Nielsen JH, Marner B, Bilde T, Ludvigsson J, Lernmark Å. Autoantibodies in newly diagnosed diabetic children immunoprecipitate human pancreatic islet cell proteins. Nature 1982;298:167.

    Google Scholar 

  41. Baekkeskov S, Dyrberg T, Lernmark Å. Autoantibodies to the 64 kilodalton islet cell protein precede the onset of spontaneous diabetes in the BB rat. Science 1984;224:1348.

    Google Scholar 

  42. Atkinson MA, Maclaren NK. Autoantibodies in nonobese diabetic mice immunoprecipitate a 64,000 Mr islet cell antigen. Diabetes 1988;37:1587.

    Google Scholar 

  43. Baekkeskov S, Landin-Olsson M, Kristensen JK, Srikanta S, Bruining GJ, Mandrup-Poulsen T, de Beaufort C, Soeldner JS, Eisenbarth G, Lindgren F, Sundquist G, Lernmark Å. Antibodies to aMr 64,000 human islet cell antigen precede the clinical onset of insulin-dependent diabetes. J Clin Invest 1987;79:926.

    Google Scholar 

  44. Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, Paquette TL. Insulin antibodies in insulin-dependent diabetes mellitus before insulin treatment. Science 1983;222:1337.

    Google Scholar 

  45. Greenbaum CJ, Palmer JP, Kuglin B, Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzymelinked immunosorbent assay: Results of the Fourth International Workshop on the Standardization of Insulin Autoantibody measurement. J Clin Endocrinol Metab 1992;74:1040.

    Google Scholar 

  46. Vardi P, Ziegler AG, Matthews JH, Dib S, Keller RJ, Ricker AT, Wolfsdorf JI, Herskowitz RD, Rabizadeh A, Eisenbarth GS, Soeldner JS. Concentration of insulin autoantibodies at onset of type I diabetes: Inverse log-linear correlation with age. Diabetes Care 1988;9:736.

    Google Scholar 

  47. Gorus FK, Vandewalle CL, Dorchy H, Van Crombrugge P, Schuit FC, Pipeleers DG, Belgian Diabetes Registry. Influence of age on the associations among insulin autoantibodies, islet cell antibodies, and HLA DQA1*0301-DQB1*0302 and siblings of patients with type 1 (insulin-dependent) diabetes mellitus. J Clin Endocrinol Metab 1995;78:1172.

    Google Scholar 

  48. Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB Study. Diabetes 1999;48:460.

    Google Scholar 

  49. Castaño L, Ziegler A, Ziegler R, Shoelson S, Eisenbarth GS. Characterization of insulin autoantibodies in relatives of patients with insulin-dependent diabetes mellitus. Diabetes 1993;42:1201.

    Google Scholar 

  50. Eisenbarth GS, Jackson GS. Insulin autoimmunity: The rate limiting factor of pre-type 1 diabetes. J Autoimmunity 1992;5:214.

    Google Scholar 

  51. Yu L, Robles DT, Abiru N, Kaur P, Rewers M, Kelemen K, Eisenbarth GS. Early expression of antiinsulin autoantibodies of humans and the NOD mouse: Evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA 2000;97:1701.

    Google Scholar 

  52. Baekkeskov S, Aanstoot HJ, Christgau S, Reetz A, Solimena M, Cascalho M, Folli F, Richter-Olesen H, De Camilli P, Camilli PD. Identification of the 64 K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature 1990;347:151.

    Google Scholar 

  53. Karlsen AE, Hagopian WA, Grubin CE, Dube S, Disteche CM, Adler DA, Barmeier H, Mathewes S, Grant FJ, Foster D, Lernmark Å. Cloning and primary structure of a human islet isoform of glutamic acid decarboxylase from chromosome 10. Proc Natl Acad Sci USA 1991;88:8337.

    Google Scholar 

  54. Michelsen BK, Petersen JS, Boel E, Møldrup A, Dyrberg T, Madsen OD. Cloning, characterization and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 1991;88:8754.

    Google Scholar 

  55. Bu D-F, Erlander MG, Hitz BC, Tillakaratne NJ, Kaufman DL, Wagner-McPherson CB, Evans GA, Tobin AJ. Two human glutamate decarboxylase, 65-kDa and 67-kDa GAD, are each encoded by a single gene. Proc Natl Acad Sci USA 1992;89:2115–2119.

    Google Scholar 

  56. Petersen JS, Russel S, Marshall Mo, Kofod H, Buschard K, Cambon N, Karlsen AE, Boel E, Hagopian WA, Hejnaes KR, Moody A, Dryberg T, Lernmark Å, Madsen OD, Michelsen BK. Differential expression of glutamic acid decarboxylase in rat and human islets. Diabetes 1993;42:484–495.

    Google Scholar 

  57. Solimena M, Aggujaro D, Muntzel C, Dirkx R, Butler M, De Camilli P, Hayday A. Association of GAD-65, but not of GAD-67, with the Golgi complex of transfected Chinese Hamster Ovary cells mediated by the N-terminal region. Proc Natl Acad Sci USA 1993;90:3073.

    Google Scholar 

  58. Solimena M, Dirkx R, Radzynski M, Mundigl O, De Camilli P. A signal located within amino acids 1-27 of GAD65 is required for its targeting to the Golgi complex region. J Cell Biology 1994;126: 331.

    Google Scholar 

  59. Porceddu A, Falorni A, Ferradini N, Consentino T, Calcinaro F, Faleri C, Crests M, Lorenzetti F, Brunetti P, Pezzotti M. Transgenic plants expressing human glutamic acid decarboxylase (GAD65), a major autoantigen in insulin-dependent diabetes mellitus. Molecular Breeding 1999;5:533.

    Google Scholar 

  60. Avesani L, Falorni A, Tornielli GB, Marusic C, Porceddu A, Polverari A, Faleri C, Calcinaro F, Pezzotti M. Improved in planta expression of the human islet autoantigen glutamic acid decarboxylase (GAD65). Transgenic Research 2003;12:203.

    Google Scholar 

  61. Sanjeevi CB, Falorni A, Robertson J, Lernmark A. Glutamic acid decarboxylase (GAD) in insulin-dependent diabetes mellitus. Diab Nutr Metab 1996;9:167.

    Google Scholar 

  62. Falorni A, Grubin CE, Takei I, Shimada A, Kasuga A, Maruyama T, Ozawa Y, Kasatani T, Saruta T, Li L, Lernmark. Radioimmunoassayu detects the frequent occurrence of autoantibodies to the Mr 65,000 isoform of glutamic acid decarboxylase in Japanese insulin-dependent diabetes. Autoimmunity 1994;19:113.

    Google Scholar 

  63. Hagopian WA, Sanjeevi CB, Kockum I, Landin-Olsson M, Karlsen AE, Sundkvist G, Dablquist G, Palmer J, Lernmark Å. Glutamate decarboxylase-, insulin-and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children. J Clin Invest 1995;95:1505.

    Google Scholar 

  64. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, Chase HP, Eisenbarth GS. Prediction of Type I diabetes in first-degree relatives using a combination of insulin, GAD and ICA512bdc/IA-2 autoantibodies. Diabetes 1996;45:926.

    Google Scholar 

  65. Örtqvist E, Falorni A, Scheynius A, Persson B, Lernmark Å. Age governs gender-dependent islet cell autoreactivity and predicts the clinical course in childhood IDDM. Acta Paediatr 1997;86: 1166.

    Google Scholar 

  66. Vandewalle CL, Falorni A, Lernmark Å, Goubert P, Dorchy H, Coucke W, Semakula C, Van der Auwera B, Kaufman L, Schuit FC, Pipeleers DG, Gorus FK. Associations of GAD65-and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. Diabetes Care 1997;20:1547.

    Google Scholar 

  67. Kasuga A, Falorni A, Maruyama T, Ozawa Y, Grubin CE, Matsubara K, Takei I, Saruta T, Scheynius A, Lernmark Å. HLA class II is associated with the frequency of glutamic acid decarboxylase Mr 65,000 autoantibodies in Japanese patients with insulin-dependent diabetes mellitus. Acta Diabetologica 1996;33:108.

    Google Scholar 

  68. Richter W, Schi Y, Baekkeskov A. Autoreactive epitopes defined by diabetes-associated human monoclonal antibodies are localized in the middle and C-terminal domains of the smaller form of glutamate decarboxylase. Proc Natl Acad Sci USA 1993;90:2832.

    Google Scholar 

  69. Richter W, Seissler J, Wolfahrt S, Scherbaum WA. Human monoclonal islet specific autoantibodies share features of islet cell and 64 kDa antibodies. Diabetologia 1993;36:785.

    Google Scholar 

  70. Ujihara N, Daw H, Gianani R, Boel E, Yu L, Powers AC. Identifi-cation of glutamic acid decarboxylase autoantibody heterogeneity and epitope regions in type I diabetes. Diabetes 1994;43:968.

    Google Scholar 

  71. Daw K, Powers AC. Two distinct glutamic acid decarboxylase autoantibody specificities in IDDM target different epitopes. Diabetes 1995;44:216.

    Google Scholar 

  72. Kaufman DL, Erlander MG, Clare-Salzler M, Atkinson MA, Maclaren NK, Tobin AJ. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J Clin Invest 1992;89:283.

    Google Scholar 

  73. Falorni A, Ackefors M, Carlberg C, Daniels T, Persson B, Robertson J, Lernmark Å. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 1996;39:1091.

    Google Scholar 

  74. Hampe CS, Hammerle LP, Falorni A, Robertson J, Lernmark Å. Site-directed mutagenesis of K396R of the 65 kDa glutamic acid decarboxylase active site obliterates enzyme activity but not antibody binding. FEBS Lett 2001;488:185.

    Google Scholar 

  75. Richter W, Jury KM, Loeffler D, Manfras BJ, Eiermann TH, Boehm BO. Immunoglobulin variable gene analysis of human autoantibodies reveals antigen-driven immune response to glutamate decarboxylase in type 1 diabetes mellitus. Eur J Immunol 1995;25:1703.

    Google Scholar 

  76. Kim J, Namchuck M, Bugawan T, Fu Q, Jaffe M, Shi Y, Aanstoot HJ, Turck CW, Erlich H, Lennon V, Baekkeskov S. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulindependent diabetes mellitus. J Exp Med 1994;180:595.

    Google Scholar 

  77. Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark Å, Miettinen A. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine sindrome type I. J Clin Endocrinol Metab 1996;81:1488.

    Google Scholar 

  78. Hallengren B, Falorni A, Landin-Olsson M, Lernmark Å, Papadopoulos KI, Sundkvist G. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients—at diagnosis and following treatment. J Intern Med 1996;239:63.

    Google Scholar 

  79. Christie MR, Vohra G, Champagne P, Daneman D, Delovitch TL. Distinct antibody specificities to a 64-kD islet cell antigen in Type 1 diabetes as revealed by tripsin treatment. J Exp Med 1990;172:789.

    Google Scholar 

  80. Rabin DU, Pleasic S, Palmer-Crocker R, Shapiro J. Cloning and expression of IDDM-specific human autoantigens. Diabetes 1992;41:183.

    Google Scholar 

  81. Lan MS, Lu J, Goto Y, Notkins AL. Molecular cloning and identi-fication of a receptor-type protein tyrosine phosphatase, IA-2, from human insulinoma. DNA Cell Biol 1994;13:505.

    Google Scholar 

  82. Bonifacio E, Lampasona V, Genovese S, Ferrari M, Bosi E. Identifi-cation of protein tyrosine phosphatase-like IA-2 (Islet Cell Antigen 512) as the insulin-dependent diabetes-related 37/40 K autoantigen and a target of islet-cell antibodies. J Immunol 1995;155: 5419.

    Google Scholar 

  83. Lu J, Li Q, Xie H, Chen ZJ, Borovitskaya AE, Maclaren NK, Notkins AL, Lan MS. Identification of a second transmembrane protein tyrosine phosphatase, IA-2, as an autoantigen in insulin-dependent diabetes mellitus: precursor of the 37-kDa tryptic fragment. Proc Natl Acad Sci USA 1996;93:2307.

    Google Scholar 

  84. Wasmeier C, Hutton JC. Molecular cloning of phogrin, a protein tyrosine phosphatase homologue localised to insulin secretory granule membranes. J Biol Chem 1996;271:18161.

    Google Scholar 

  85. Bearzatto M, Naserke H, Piquer S, Koczwara K, Lampasona V, Williams A, Christie MR, Bingley PJ, Ziegler AG, Bonifacio E. Two distinctly HLA-associated contiguous linear epitopes uniquely expressed within the islet antigen 2 molecule are major autoantibody epitopes of the diabetes-specific tyrosine phosphatase-like protein autoantigens. J Immunol 2002;168:4202.

    Google Scholar 

  86. Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Diabetologia 1997;40:95.

    Google Scholar 

  87. Pietropaolo M, Castaño L, Babu S, Buelow R, Kuo Y-LS, Martin S, Martin A, Powers AC, Prochazka M, Leiter EH, Eisenbarth GS. Islet cell autoantigen 69 kD (ICA69). Molecular clonino and characterization of a novel diabetes-associated autoantigen. J Clin Invest 1993;92:359.

    Google Scholar 

  88. Lampasona V, Ferrari M, Bosi E, Pastore MR, Bingley PJ, Bonifacio E. Sera from patients with IDDM and healthy individuals have antibodies to ICA69 on western blots but do not immunoprecipitate liquid phase antigen. J Autoimmun 1994;7:665.

    Google Scholar 

  89. Kasimiotis H, Myers MA, Argentaro A, Mertin S, Fida S, Ferraro T, Olsson J, Rowley MJ, Harley VR. Sex-determing region Y-related protein SOX13 is a diabetes autoantigen expressed in pancreatic islets. Diabetes 2000;49:555.

    Google Scholar 

  90. Lampasona V, Scirpoli M, Bosi E, Bonifacio E. ICA12 (SOX13) autoantibodies are unlikely to be a useful marker for pre-clinical Type I diabetes. Diabetologia 2001;44:267.

    Google Scholar 

  91. Petersen JS, Kulmala P, Clausen JT, Knip M, Dyrberg T, Childhood Diabetes in Finland Study Group. Progression to type 1 diabetes is associated with a change in the immunoglobulin isotype profile of autoantibodies to glutamic acid decarboxylase. Clin Immunol 1999;2:276.

    Google Scholar 

  92. Maclaren NK, Riley WJ. Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care 1985;8(suppl.1):34.

    Google Scholar 

  93. Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in chidlren and adolescents with type 1 diabetes: A multicenter survey. Diabetes Care 2002;25:1346.

    Google Scholar 

  94. Riley WJ, Toskes PP, Maclaren NK, Silverstein JH. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin-dependent diabetes. Diabetes 1982;31:1051.

    Google Scholar 

  95. Hagglof B, Rabinovitch A, Mackay P, Huen A, Rubenstein AH, Marner B, Nerup J, Lernmark Å. Islet cell and other organ-specific autoantibodies in healthy first-degree relatives to insulin-dependent diabetes. Acta Paediatr Scand 1986;75:611.

    Google Scholar 

  96. Lampasona V, Bonfanti R, Bazzigaluppi E, Venerando A, Chiumello G, Bosi E, Bonifacio E. Antibodies to tissue transglutaminase in type I diabetes. Diabetologia 1999;42:1195.

    Google Scholar 

  97. Falorni A, Laureti S. Adrenal autoimmunity and correlation with adrenal dysfunction. The Endocrinologist 2000;10:145.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Perugia, Perugia, Italy

    Alberto Falorni & Filippo Calcinaro

Authors
  1. Alberto Falorni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Filippo Calcinaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Falorni, A., Calcinaro, F. Humoral Responses in Type 1 Diabetes Mellitus. Rev Endocr Metab Disord 4, 281–290 (2003). https://doi.org/10.1023/A:1025108530242

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025108530242

Search

Navigation